EcoDrugPlus

Ensembl ID : ML063310a
Gene Symbol: -
External references: -
349 Possible Orthologues:

Ensembl ID : ML063329a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML06333a
Gene Symbol: -
External references: -
268 Possible Orthologues:

Ensembl ID : ML06337a
Gene Symbol: -
External references: -
349 Possible Orthologues:

Ensembl ID : ML06338a
Gene Symbol: -
External references: -
349 Possible Orthologues:

Ensembl ID : ML06339a
Gene Symbol: -
External references: -
349 Possible Orthologues:

Ensembl ID : ML06394a
Gene Symbol: -
External references: -
105 Possible Orthologues:

Ensembl ID : ML06406a
Gene Symbol: -
External references: -
461 Possible Orthologues:

Ensembl ID : ML06407a
Gene Symbol: -
External references: -
461 Possible Orthologues:

Ensembl ID : ML064510a
Gene Symbol: -
External references: -
84 Possible Orthologues:

Ensembl ID : ML064939a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).